Pacific Biosciences of California, Inc. (PACB)

NMS – Real Time Price. Currency in USD

1.10

-0.04 (-3.54%)

Market open: Aug 12, 2026, 11:33 AM EDT

1.16

+0.02 (1.71%)

Previous after-hours: Aug 11, 2026, 7:52 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

160M

154M

201M

128M

Cost of goods sold

-479M

-130M

-160M

-79M

Gross Profit

-319M

24M

40M

49M

Operating expenses (excl. COGS)

-233M

-289M

-351M

-354M

Operating Income

-552M

-265M

-310M

-305M

Non-operating income, total

-44M

-8M

-9M

Pretax income

-546M

-310M

-318M

-314M

Equity in earnings

Taxes

-318K

-316K

11M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-546M

-310M

-307M

-314M

Discontinued operations

Net income

-546M

-310M

-307M

-314M

Dilution adjustment

-148M

Preferred dividends

Pacific Biosciences of California, Inc. (PACB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pacific Biosciences of California, Inc. (PACB)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Pacific Biosciences of California, Inc. (PACB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pacific Biosciences of California, Inc. (PACB)

Income Statement (Annual)

Income Statement (Annual)